新辅助治疗对低位直肠癌经内外括约肌间切除术后肛门功能的影响

丛进春; 陈春生; 冯勇; 马明星; 夏志秀; 刘鼎盛

doi:10.3969/j.issn.1000-8179.20130052

新辅助治疗对低位直肠癌经内外括约肌间切除术后肛门功能的影响

doi: 10.3969/j.issn.1000-8179.20130052

中国医科大学附属盛京医院结直肠肿瘤外科（沈阳市 110004）

基金项目:

辽宁省教育厅项目 L2010609

辽宁省科学技术厅项目 2011225019

详细信息

通讯作者:
陈春生 chenchunsheng@sj-hospital.org

计量
- 文章访问数: 49
- HTML全文浏览量: 9
- PDF下载量: 2
- 被引次数: 0
出版历程
- 收稿日期: 2013-07-17
- 修回日期: 2013-09-06

Effects of neoadjuvant chemoradiotherapy on anal sphincter function for intersphincteric resection with low rectal cancer

Department of Colorectal Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, China

Funds:

the Scientific Research Project Funds of Liaoning Provincial Department of Education L2010609

the Liaoning Provincial Department of Science and Technology 2011225019

More Information

Corresponding author: Chunsheng CHEN; E-mail: chenchunsheng@sj-hospital.org

摘要

摘要: 目的进展期的低位直肠癌行新辅助治疗可明显降低局部复发，但是也可能会带来肛门功能的受损。本研究探讨新辅助治疗对经内外括约肌间切除术（intersphincteric resection，ISR）术后肛门功能的影响程度。方法选取2005年9月至2011年3月中国医科大学附属盛京医院103例行ISR手术的低位直肠癌患者，按照是否接受术前新辅助治疗分为CRT组（术前放化疗组）和对照组，通过向量测压、Saito功能问卷和Wexner评分来比较两组的肛门功能。结果 CRT组的术前静息向量容积和收缩向量容积要明显低于对照组，术后两组的测压结果均显著下降，CRT组的所有指标均低于对照组（P < 0.05）。在6、12个月Saito功能问卷结果除排便困难两组间没有差异外，其余CRT组结果均明显不如对照组；在术后24个月，排便频率、排便截断、气便分辨能力以及限制饮食4项CRT组仍不及对照组（P < 0.05）。到术后24个月，两组Wexner评分均有下降趋势，CRT组高于对照组（P < 0.05）。结论对于需行ISR手术的低位直肠癌，新辅助治疗会明显的影响术后的肛门功能，而且这种影响要至少会持续2年时间。
- 直肠癌 /
- 新辅助放化疗 /
- 经内外括约肌间切除术 /
- 肛门功能
Abstract: Objective To evaluate the effects of neoadjuvant chemoradiotherapy on anal function after intersphincteric resection (ISR) with low rectal cancer. Methods A total of 103 patients were classified into the chemoradiotherapy (CRT) group and control group according to whether they received neoadjuvant chemoradiotherapy. Anal function was assessed using vectorial manometry, Saito function questionnaires, and Wexner incontinence scores. Results The resting vector volume and squeezing vector volume of the CRT group were significantly lower than those of the control group prior to the operation. Both groups showed decreasing manometric results after ISR. However, all indices of the CRT group were significantly lower than those of the control group (P < 0.05). At 6 and 12 months after operation, the Saito questionnaire results reveal poor function for the CRT group compared with the control group, except for dyschesia. After 24 months, the stool frequency, ability to distinguish between feces and flatus, fragmentation, and alimentary restriction remained poor for the CRT group (P < 0.05). Although both groups showed decreasing Wexner scores with time, the score of the CRT group remained significantly higher than that of the control up to 24 months after operation. Conclusion Neoadjuvant chemoradiotherapy significantly affects the anal sphincter function for intersphincteric resection with low rectal cancer. This effect continues for at least 2 years after operation.
- rectal cancer /
- neoadjuvant chemoradiotherapy /
- intersphincteric resection /
- anal sphincter function

HTML全文

表 1 一般资料

Table 1. Clinical data of the patients

表 2 向量测压结果

Table 2. Vectorial manometric results

表 3 肛门功能问卷调查

Table 3. Results of the questionnaire survey on anal function

参考文献(20)

[1]	Monson JR, Weiser MR, Buie WD, et al. Standards Practice Task Force of the American Society of Colon and Rectal Surgeons. Practice parameters for the management of rectal cancer (revised)[J]. Dis Colon Rectum, 2013, 56(5): 535-550. doi: 10.1097/DCR.0b013e31828cb66c
[2]	Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial[J]. Lancet, 2009, 373(9666): 811-820. doi: 10.1016/S0140-6736(09)60484-0
[3]	Bosset JF, Collette L, Calais G, et al. EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer[J]. N Engl J Med, 2006, 355(11): 1114-1123. doi: 10.1056/NEJMoa060829
[4]	Birgisson H, Påhlman L, Gunnarsson U, et al. Swedish Rectal Cancer Trial Group. Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial[J]. J Clin Oncol, 2005, 23(34): 8697-8705. doi: 10.1200/JCO.2005.02.9017
[5]	Wong RK, Tnadan V, De Silva S, et al. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma[J]. Cochrane Database Syst Rev, 2007, 2: CD002102.
[6]	Schiessel R, Karner-Hanusch J, Herbst F, et al. Intersphincteric resection for low rectal cancer tumors[J]. Br J Surg, 1994, 81(9): 1376-1378.
[7]	Martin ST, Heneghan HM, Winter DC. Systematic review of outcomes after intersphincteric resection for low rectal cancer[J]. Br J Surg, 2012, 99(5): 603-612. doi: 10.1002/bjs.8677
[8]	Hohenberger W, Merkel S, Matzel K, et al. The influence of abdomino-peranal (intersphincteric) resection of lower third rectal carcinoma on the rates of sphincter preservation and locoregional recurrence[J]. Colorectal Dis, 2006, 8(1): 23-33. doi: 10.1111/j.1463-1318.2005.00839.x
[9]	Rullier E, Laurent C, Bretagnol F, et al. Sphincter-saving resection for all rectal carcinomas: the end of the 2-cm distal rule[J]. Ann Surg, 2005, 241(3): 465-469. doi: 10.1097/01.sla.0000154551.06768.e1
[10]	Bonadeo FA, Vaccaro CA, Benati ML, et al. Rectal cancer: local recurrence after surgery without radiotherapy[J]. Dis Colon Rectum. 2001, 44(3): 374-379. doi: 10.1007/BF02234736
[11]	Ito M, Saito N, Sugito M, et al. Analysis of clinical factors associated with anal function after intersphincteric resection for very low rectal cancer[J]. Dis Colon Rectum, 2009, 52(1): 64-70. doi: 10.1007/DCR.0b013e31819739a0
[12]	Chamlou R, Parc Y, Simon T, et al. Long-term results of intersphincteric resection for low rectal cancer[J]. Ann Surg, 2007, 246 (6): 916-922. doi: 10.1097/SLA.0b013e31815c29ff
[13]	Saito N, Ono M, Sugito M, et al. Early results of intersphincteric resection for patients with very low rectal cancer: an active approach to avoid a permanent colostomy[J]. Dis Colon Rectum, 2004, 47(4): 459-466 doi: 10.1007/s10350-003-0088-4
[14]	Jorge JM, Wexner SD. Etiology and management of fecal incontinence[J]. Dis Colon Rectum, 1993, 36(1): 77-97. doi: 10.1007/BF02050307
[15]	丛进春, 戴显伟, 张宏, 等. 超低位直肠癌经括约肌间切除术后的肛门功能评价[J]. 中国现代医学杂志, 2008, 18(6): 795-798. doi: 10.3969/j.issn.1005-8982.2008.06.034
[16]	Nishizawa Y, Fujii S, Saito N, et al. The association between anal function and neural degeneration after preoperative chemoradiotherapy followed by intersphincteric resection. [J]. Dis Colon Rectum, 2011, 54(11): 1423-1429. doi: 10.1097/DCR.0b013e31822c94e6
[17]	Haboubi NY, Path MR, Schofield PF, et al. The light and electron microscopic features of early and late phase radiation-induced proctitis[J]. Am J Gastroenterol, 1988, 83(10): 1140-1144.
[18]	Fajardo LF. The unique physiology of endothelial cells and its implications in radiobiology[J]. Front Radiat Ther Oncol, 1989, 23: 96-112.
[19]	Fujii S, Yamamoto S, Ito M, et al. Short-term outcomes of laparoscopic intersphincteric resection from a phase Ⅱ trial to evaluate laparoscopic surgery for stage 0/I rectal cancer: Japan Society of Laparoscopic Colorectal Surgery Lap RC. [J]. Surg Endosc, 2012, 26 (11): 3067-3076. doi: 10.1007/s00464-012-2317-1
[20]	Lim SW, Huh JW, Kim YJ, et al. Laparoscopic intersphincteric resection for low rectal cancer[J]. World J Surg, 2011, 35(12): 2811-2817. doi: 10.1007/s00268-011-1277-2